Mostrar el registro sencillo del ítem

dc.contributor.authorPadron-Monedero, Alicia 
dc.contributor.authorKoru-Sengul, Tulay
dc.contributor.authorTannenbaum, Stacey L
dc.contributor.authorMiao, Feng
dc.contributor.authorHansra, Damien
dc.contributor.authorLee, David J
dc.contributor.authorByrne, Margaret M
dc.date.accessioned2021-01-25T09:25:23Z
dc.date.available2021-01-25T09:25:23Z
dc.date.issued2015-10
dc.identifier.citationBreast Cancer Res Treat . 2015 Oct;153(3):679-87es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/11656
dc.description.abstractThe purpose of the article was to assess whether smoking affects survival in male breast cancer patients for the overall population and when stratified by race, ethnicity, and socioeconomic status. Data were obtained by linking the 1996-2007 Florida Cancer Data System, the Florida Agency for Health Care Administration, and the US Census. Inclusion criteria were males ≥18 years, diagnosed with breast cancer and residing in Florida (n = 1573). To analyze the association between smoking and survival, we performed sequential multivariate Cox proportional hazards regression models with progressive adjustment for main confounders. Compared to never smokers, worse survival was found in current (hazard ratio = 1.63; 95 % CI = 1.23-2.16) but not in former smokers (1.26; 0.99-1.59). Those who smoked ≥1 packs/day had worse survival (2.48; 1.59-3.87) than never smokers with a significant dose-response (P for linear trend <0.001). Race-ethnic stratified models comparing current and former smokers with never smokers found significant differences among Whites [(1.88; 1.44-2.44) and (1.31; 1.04-1.65, respectively)] and non-Hispanics, [(1.73; 1.31-2.28) and (1.31; 1.04-1.66, respectively)]. Overall, current smokers were found to have significantly reduced survival, which was worse by intensity of smoking. Also, any smoking history is associated with worse survival in White and non-Hispanic male breast cancer patients compared to never smokers. Thus, male breast cancer patients should be advised to quit smoking.es_ES
dc.description.sponsorshipThis study was funded by the James & Esther King Florida Biomedical Research Program (Grant 10KG-06).es_ES
dc.language.isoenges_ES
dc.publisherSpringer es_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectHealth inequalitieses_ES
dc.subjectMale breast canceres_ES
dc.subjectSmokinges_ES
dc.subjectSurvivales_ES
dc.subject.meshSmoking es_ES
dc.subject.meshAdult es_ES
dc.subject.meshAged es_ES
dc.subject.meshAged, 80 and over es_ES
dc.subject.meshBreast Neoplasms, Male es_ES
dc.subject.meshComorbidity es_ES
dc.subject.meshFlorida es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshModels, Statistical es_ES
dc.subject.meshMortality es_ES
dc.subject.meshPopulation Surveillance es_ES
dc.subject.meshRegistries es_ES
dc.subject.meshSocioeconomic Factors es_ES
dc.titleSmoking and survival in male breast cancer patients.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID26409835es_ES
dc.format.volume153es_ES
dc.format.number3es_ES
dc.format.page679-87es_ES
dc.identifier.doi10.1007/s10549-015-3582-1es_ES
dc.contributor.funderJames & Esther King Florida Biomedical Research Program
dc.description.peerreviewedes_ES
dc.identifier.e-issn1573-7217es_ES
dc.relation.publisherversionhttps://doi.org/10.1007/s10549-015-3582-1es_ES
dc.identifier.journalBreast cancer research and treatmentes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional